Dr. Melissa Fain, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 145 Newcomb Ave, Mount Vernon, KY 40456 Phone: 606-256-2195 Fax: 606-256-7742 |
Kendall Keith Kilbourne, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 410 Richmond, Mount Vernon, KY 40456 Phone: 606-256-3447 |
Renzee Jade Jarvis, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 116 Progress Dr, Mount Vernon, KY 40456 Phone: 606-256-2143 |
Jessica Boggs, PHARMD Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 116 Progress Dr, Mount Vernon, KY 40456 Phone: 606-256-2143 |
Ms. Tanya M Brock, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1040 Richmond St, Mount Vernon, KY 40456 Phone: 606-256-9207 |
Mrs. Jamie D. Jones, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 110 Newcomb Ave, Rockcastle Professional Pharmacy, Mount Vernon, KY 40456 Phone: 606-256-4613 Fax: 606-256-9120 |
Melissa Danette Harris-craig, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1040 Richmond St, Mount Vernon, KY 40456 Phone: 606-256-9207 |
News Archive
Geisinger Health System's Genomic Medicine Institute has been approved to receive a $1.4 million research award from the Patient-Centered Outcomes Research Institute (PCORI) to study how best to share genomic lab results with patients.
After suffering a stroke, about three-fourths of patients exhibit some disability. The extent of a patient's symptoms depends on the degree and location of brain tissue damage following the stroke event. This week in ACS Central Science, researchers show that by using a tailored small molecule to turn off the production of a key neuromodulator in the brain, they can dramatically reduce brain damage in stroke models in rats.
Patients who have taken antidepressants for years should consider coming off the medication. However, researchers say they will likely face difficult and even dangerous withdrawal symptoms due to a physical dependence.
With the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) across most of the world, scientists are working strenuously to find effective therapies or vaccines. Most strategies being worked on at present are targeting viral entry into the host cells, mainly through the interaction of the SARS-CoV-2 S protein with the angiotensin-converting enzyme 2 (ACE2) receptor.
Johns Hopkins researchers have used fruit flies to gain new insights into a brain-damaging disorder afflicting children.
› Verified 7 days ago